Corteva (CTVA) Stock Forecast & Price Target

$71.46 +0.27 (+0.38%)

As of 06/4/2025 03:59 PM Eastern

Corteva - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 16 Analyst Ratings

Sell
1

Hold
3

Buy
12

Based on 16 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 1 has given a sell rating, 3 have given a hold rating, and 12 have given a buy rating for CTVA.

Consensus Price Target

$70.50
-1.34% Downside

According to the 16 analysts' twelve-month price targets for Corteva, the average price target is $70.50. The highest price target for CTVA is $79.00, while the lowest price target for CTVA is $55.00. The average price target represents a forecasted downside of -1.34% from the current price of $71.46.

Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

CTVA Analyst Ratings Over Time

Type	Current Forecast 6/5/24 to 6/5/25	1 Month Ago 5/6/24 to 5/6/25	3 Months Ago 3/7/24 to 3/7/25	1 Year Ago 6/6/23 to 6/5/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)	15 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	6 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$70.50	$68.43	$67.79	$63.05
Forecasted Upside	-1.34% Downside	9.47% Upside	11.82% Upside	16.63% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Corteva Stock vs. The Competition

Type	Corteva	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.69	2.52	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	-1.34% Downside	51.61% Upside	14.42% Upside
News Sentiment Rating	Positive News See Recent CTVA News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
5/14/2025	Barclays 3 of 5 stars	Benjamin Theurer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Equal Weight ➝ Equal Weight	$64.00 ➝ $70.00	+4.52%
5/12/2025	Wells Fargo & Company 3 of 5 stars	Richard Garchitorena Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$73.00 ➝ $79.00	+16.75%
5/9/2025	Oppenheimer 3 of 5 stars	Kristen Owen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$72.00 ➝ $75.00	+11.05%
5/9/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Patrick Cunningham Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$75.00 ➝ $78.00	+15.86%
5/9/2025	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Vincent Andrews Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$65.00 ➝ $71.00	+5.47%
5/9/2025	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Aleksey Yefremov Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$71.00 ➝ $72.00	+7.49%
5/8/2025	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Joshua Spector Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$74.00 ➝ $76.00	+14.17%
3/31/2025	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Bill Selesky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$69.00 ➝ $69.00	+12.96%
3/13/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Duffy Fischer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$71.00	+20.19%
2/11/2025	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Steve Byrne Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$69.00 ➝ $73.00	+17.36%
Get the Latest News and Ratings for CTVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corteva and its competitors with MarketBeat's FREE daily newsletter.
2/10/2025	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Favre Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
2/7/2025	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Arun Viswanathan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$72.00 ➝ $73.00	+17.09%
8/2/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$57.00 ➝ $55.00	+6.63%
6/18/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$61.00 ➝ $60.00	+15.27%
6/12/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$65.00 ➝ $65.00	+25.90%
6/7/2024	OTR Global Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Mixed ➝ Negative
5/3/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$60.00 ➝ $65.00	+13.72%
5/3/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$64.00 ➝ $67.00	+17.13%
3/1/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$67.00	+25.30%
2/12/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$57.00 ➝ $65.00	+21.27%
11/27/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$63.00 ➝ $52.00	+11.42%
11/22/2023	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$82.00 ➝ $63.00	+36.45%
8/4/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$74.00	+31.95%
7/25/2023	Redburn Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:30 AM ET.

Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, June 3, 2025. Please send any questions or comments about these Corteva pros and cons to [email protected].

Corteva
Bull Case

Here are some ways that investors could benefit from investing in Corteva, Inc.:

The current stock price is around $70.93, reflecting a recent increase, which may indicate positive market sentiment towards the company.
Corteva, Inc. reported earnings per share (EPS) of $1.13, surpassing analyst expectations, which suggests strong financial performance and potential for future growth.
Analysts have issued a consensus target price of approximately $70.50, indicating that there is room for price appreciation based on current valuations.
The company has a solid dividend yield of 0.96%, providing investors with a steady income stream, which is attractive in a low-interest-rate environment.
Institutional ownership stands at 81.54%, suggesting strong confidence from large investors, which can be a positive indicator for retail investors.

Corteva
Bear Case

Investors should be bearish about investing in Corteva, Inc. for these reasons:

The company experienced a revenue decline of 1.7% compared to the same quarter last year, which may raise concerns about its growth trajectory.
Corteva has a relatively high price-to-earnings (P/E) ratio of 54.98, which could indicate that the stock is overvalued compared to its earnings, making it a riskier investment.
Despite positive earnings, the company fell short of revenue expectations, which could signal potential challenges in meeting future growth targets.
One analyst has rated the stock with a sell rating, which may reflect concerns about the company's long-term prospects.
The market's volatility could impact Corteva's stock performance, especially given its beta of 0.72, indicating it is less volatile than the market but still subject to fluctuations.

CTVA Forecast - Frequently Asked Questions

: According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $70.50, with a high forecast of $79.00 and a low forecast of $55.00.
: 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There is currently 1 sell rating, 3 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CTVA shares.
: According to analysts, Corteva's stock has a predicted downside of -1.34% based on their 12-month stock forecasts.
: Over the previous 90 days, Corteva's stock had 1 upgrade by analysts.
: Corteva has been rated by research analysts at Argus, Barclays, Citigroup, KeyCorp, Morgan Stanley, Oppenheimer, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Corteva more than other "consumer staples" companies. The consensus rating score for Corteva is 2.69 while the average consensus rating score for "consumer staples" companies is 2.52. Learn more on how CTVA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CTVA) was last updated on 6/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Corteva (CTVA) Stock Forecast & Price Target